Meprobamate
Meprobamate—marketed as Miltown by Wallace Laboratories and Equanil by Wyeth, among others—is a carbamate derivative used as an anxiolytic drug. It was the best-selling minor tranquilizer for a time, but has largely been replaced by the benzodiazepines due to their wider therapeutic index (lower risk of toxicity at therapeutically prescribed doses) and lower incidence of serious side effects.
Clinical data | |
---|---|
Trade names | Miltown, Equanil, Meprospan, Amepromat, Quivet, Zirponand, and many others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682077 |
Pregnancy category |
|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | Hepatic |
Elimination half-life | 10 hours |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.306 |
Chemical and physical data | |
Formula | C9H18N2O4 |
Molar mass | 218.253 g·mol−1 |
3D model (JSmol) | |
Density | 1.229 g/cm3 |
Melting point | 105 to 106 °C (221 to 223 °F) |
Boiling point | 200 °C (392 °F) to 210 °C (410 °F) |
| |
| |
(verify) |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.